14. Post-Extubation Failure & Reintubation

Quick Recap

Tier 1 expansion protocol — companion to Acute Respiratory Failure and ARDS protocols in this system. Addresses the peri-extubation window: predicting failure, executing safe extubation, and managing the patient who deteriorates after planned extubation.

1. Definition

Extubation failure: need for reintubation within 48–72 hours of a planned extubation following a successful spontaneous breathing trial (SBT). Some surveillance definitions extend to 7 days, but 48–72 hours is the operational definition used in most trial data and quality metrics.

Reported reintubation rates are 11–23.5% even in patients deemed ready for extubation by all objective criteria — failure occurs despite a technically successful SBT, which is why post-extubation surveillance is a distinct clinical problem from weaning readiness itself.

Related but distinct entities:

• Weaning failure: failure of the SBT itself (patient never reaches extubation)
• Difficult-to-wean: failure to wean within 48–72 hours of resolution of the underlying disease process ("WEANS NOW" framework, Section 7)
• Post-extubation respiratory failure: new distress after extubation that may or may not progress to reintubation — the broader category this protocol addresses
• Post-extubation laryngeal edema/stridor: a specific mechanical subtype of failure

2. Pathophysiology

Extubation failure is a final common pathway from several distinct mechanisms, and the mechanism should dictate the rescue strategy:

Load–capacity mismatch (most common): the tube and ventilator were substituting for inadequate respiratory muscle capacity or increased ventilatory load (secretions, bronchospasm, stiff lungs). Diaphragm strength recovers slowly after even short periods of controlled ventilation (ventilator-induced diaphragmatic dysfunction), so capacity may remain reduced despite a passed SBT.

Upper airway obstruction: laryngeal edema from tube trauma, prolonged intubation, or traumatic intubation narrows the airway once the tube — which was splinting it open — is removed. Typically presents as stridor within minutes to hours.

Cardiac mechanism: positive pressure ventilation reduces LV preload and afterload; extubation abruptly increases negative intrathoracic pressure swings, raising LV afterload and venous return simultaneously. In patients with diastolic dysfunction this precipitates flash pulmonary edema ("cardiogenic extubation failure"). Elevated E/e′ on pre-extubation echocardiography predicts this mechanism.

Secretion burden / inability to protect the airway: weak cough, excess secretions, or depressed consciousness leads to retained secretions, atelectasis, and aspiration independent of respiratory muscle strength.

Delirium/agitation-driven distress: a neuropsychiatric rather than pulmonary/cardiac trigger, but can present identically.

3. Immediate Stabilization (ABCDE) — Patient Deteriorating Post-Extubation

Airway

Breathing

Circulation

Disability

Exposure

Decision point: signs of impending failure (RR >35, accessory muscle use, SpO2 <90% on adequate O2, hemodynamic instability, altered mental status, inability to clear secretions) → do not delay reintubation to trial rescue NIV/HFNC further. Delayed reintubation in a deteriorating patient is associated with worse outcomes than early reintubation.

4. Focused History (Pre-Extubation Risk Assessment)

• Indication and duration of intubation (>7 days increases risk of both laryngeal injury and diaphragmatic dysfunction)
• Reason for prior failed extubation, if any
• Traumatic or difficult intubation (increases laryngeal edema risk)
• Known or suspected difficult airway
• Cardiac history: LV dysfunction, diastolic dysfunction, prior flash pulmonary edema
• COPD / chronic hypercapnia — different weaning and post-extubation O2 strategy
• Neuromuscular disease or critical illness myopathy/neuropathy
• Baseline functional status, frailty, cough strength
• Fluid balance over the preceding 24–48 hours
• Sedation load and duration; delirium history during this admission
• Nutritional status
• Age >65, especially combined with other risk factors

5. Comprehensive System-wise Examination (Pre-Extubation)

• Respiratory: air entry, secretions burden and character, cough strength (ability to generate an effective cough on suctioning), accessory muscle use at baseline
• Cardiovascular: volume status, JVP, signs of fluid overload, murmurs
• Neurological: GCS/RASS, ability to follow commands, gag and swallow assessment
• ENT/Airway: direct or video laryngoscopic view if prior traumatic intubation or prolonged intubation is a concern
• Musculoskeletal: visible muscle wasting, ICU-acquired weakness (MRC sum score if feasible)

POCUS integration: diaphragm ultrasound (excursion, thickening fraction), lung ultrasound score (LUS), and echocardiographic E/e′ are now validated adjuncts to predict extubation outcome (Section 10).

6. Syndrome Identification

Before labeling a post-extubation event, identify the dominant syndrome driving it:

• Upper airway obstruction (stridor pattern)
• Load–capacity respiratory failure (fatigue pattern)
• Cardiogenic pulmonary edema (flash pattern)
• Aspiration / secretion retention (atelectasis/consolidation pattern)
• Delirium-driven distress (agitation without true gas exchange failure)
• Mixed/multifactorial (common in the frail or elderly)

7. Differential Diagnosis of Post-Extubation Deterioration

Life-threatening / must-not-miss:

• Laryngeal edema with impending complete obstruction
• Flash pulmonary edema
• Aspiration pneumonitis
• Pneumothorax (post-procedural or barotrauma-related)
• Mucus plugging with lobar collapse

Common causes:

• Respiratory muscle fatigue / load-capacity mismatch
• Secretion retention with ineffective cough
• Mild laryngeal edema / stridor

Must-not-miss in the difficult-to-wean patient — "WEANS NOW" framework:

• Weaning parameters inadequate
• Endotracheal tube (undersized, kinked, obstructed)
• ABG derangement (metabolic alkalosis blunting drive; inappropriate PaCO2 target in chronic retainers)
• Nutrition (over- or under-feeding, electrolyte deficiency)
• Secretions (excessive, poorly cleared)
• Neuromuscular factors (blockers, aminoglycosides, clindamycin, unnecessary steroids)
• Obstruction of airway (bronchospasm, foreign body)
• Wakefulness (oversedation)

Iatrogenic: residual neuromuscular blockade, oversedation, excessive positive fluid balance

Drug-induced: opioid-induced hypoventilation, benzodiazepine accumulation

8. Severity Assessment

• Rapid Shallow Breathing Index (RSBI) = RR/Vt: <105 breaths/min/L during SBT associated with higher extubation success (historic cutoff of 100 also cited — Yang & Tobin, NEJM 1991); useful but insufficient as a sole determinant
• Cuff-leak test: pooled sensitivity 0.66, specificity 0.88 for reintubation risk (Kuriyama et al., Crit Care 2020); high negative predictive value — most useful for reassurance when leak is present, less reliable for ruling in failure when absent
• MRC sum score for ICU-acquired weakness (<48 suggests significant weakness)
• CAM-ICU / RASS for delirium and sedation depth
• SOFA trend to track overall trajectory

9. Investigations

Immediate bedside:

• ABG (pre- and post-extubation if high risk)
• Cuff-leak test if laryngeal edema risk factors present
• Bedside spirometry / RSBI during SBT

Routine labs: electrolytes (especially phosphate, magnesium — neuromuscular relevance), CBC, renal function

Imaging: CXR pre-extubation (assess for effusion, atelectasis, consolidation) and post-extubation if deterioration occurs

Advanced / POCUS (Section 10): diaphragm ultrasound, lung ultrasound score, echocardiography (E/e′, LV function)

Repeat frequency: continuous SpO2/RR monitoring for at least 24 hours post-extubation in high-risk patients; ABG at 1 hour post-extubation if borderline, then as clinically indicated

10. Point-of-Care Ultrasound

Diaphragm ultrasound: excursion and thickening fraction (TFdi) during tidal breathing and SBT. Reduced excursion/TFdi predicts weaning and extubation failure and identifies diaphragmatic dysfunction as the mechanism, redirecting management toward respiratory muscle rest and rehabilitation rather than repeated aggressive weaning attempts.

Lung ultrasound score (LUS): higher scores (more B-lines/consolidation) pre-extubation correlate with extubation failure.

Echocardiography: E/e′ ratio and evidence of diastolic dysfunction pre-extubation flag patients at risk for cardiogenic extubation failure — consider a fluid-restrictive strategy and pre-emptive diuresis before extubation in this subgroup, and have NIV/nitrates ready at the bedside.

Airway ultrasound (emerging, not yet fully validated): air column width measurement as an adjunct to the cuff-leak test.

11. Evidence-Based Management

Pre-Extubation (readiness confirmation)

• Confirm SBT success: RR <35/min, stable hemodynamics, minimal accessory muscle use, no significant anxiety, SpO2 maintained
• SBT duration of 30 minutes is at least equivalent to longer trials for predicting success (allows daily trials without excessive fatigue)
• Pressure support ventilation (PSV) trials are at least as effective as T-piece trials, with lower SBT failure rates — PSV is now the more commonly used modality
• Extubation checklist: alert/easily arousable, intact airway reflexes, manageable secretions, FiO2 <0.4 with PEEP <5 and SpO2 >94%, hemodynamically stable, PaCO2 <50 (or at baseline for chronic retainers), pH 7.30–7.47, core temp <38.5°C, NPO ≥4 hours

Laryngeal Edema Prevention (in patients with risk factors or absent cuff leak)

• Prophylactic corticosteroids: at least two doses, first dose given 4–12 hours (ideally ≥12h) pre-extubation — multi-dose regimens given well before extubation are more effective than single-dose regimens given immediately prior (Francois et al., Lancet 2007; Fan et al., BMJ 2008 meta-analysis)
• Example regimen: dexamethasone 0.2 mg/kg IV q6h, first dose 12 hours pre-extubation, continued up to 48 hours post-extubation

First Hour Post-Extubation

• Transition to appropriate O2 modality based on risk stratification (below)
• Encourage coughing and clear secretions within first minutes
• Continuous monitoring: RR, SpO2, work of breathing, mental status
• Keep reintubation equipment at bedside for at least 1 hour in high-risk patients

Post-Extubation Oxygenation Strategy — Risk-Stratified

If Stridor Develops

• Nebulized racemic epinephrine (vasoconstriction, reduces edema)
• IV corticosteroids (short course, ~48h) — no strong RCT evidence but standard practice
• Heliox in non-distressed patients to buy time for steroids to act
• Low threshold for reintubation if any sign of distress or progressive narrowing — do not delay

First 24 Hours

• Continue close monitoring; most extubation failures occur within this window
• Daily reassessment of secretion burden, cough strength, mental status
• Early mobilization and physiotherapy to support respiratory muscle recovery
• Nutrition optimization (avoid under- and over-feeding)

12. Organ Support

• Respiratory: HFNC/NIV per risk stratification above; escalate to invasive ventilation without delay if failing
• Cardiovascular: diuresis/nitrates if cardiogenic mechanism; avoid unnecessary fluid loading peri-extubation
• Nutrition: maintain adequate protein/caloric intake through the peri-extubation period to support respiratory muscle recovery; avoid interruption of feeds purely for extubation logistics beyond the required fasting window
• Sedation/analgesia: targeted light sedation (or none) in the pre- and post-extubation window; avoid re-sedating a patient who becomes agitated without first excluding hypoxia/hypercapnia as the cause

13. Disease-Specific Therapy

• Dexamethasone 0.2 mg/kg IV q6h ×4 doses pre-extubation for laryngeal edema prophylaxis in high-risk patients (absent/reduced cuff leak, traumatic intubation, prolonged intubation, female sex, large tube-to-larynx ratio)
• Nebulized racemic epinephrine for established post-extubation stridor
• Diuretics/nitrates for cardiogenic extubation failure
• Bronchodilators if obstructive component contributing to load
• Avoid neuromuscular-depressing drugs (aminoglycosides, clindamycin, residual paralytics) in patients with borderline muscle strength

14. Consultation Matrix

15. Monitoring Framework

• Clinical: continuous RR, SpO2, work of breathing assessment at minimum hourly for first 4 hours, then per risk category
• Hemodynamic: continuous ECG/BP monitoring, especially in patients at risk for cardiogenic failure
• Laboratory: ABG at 1 hour post-extubation if borderline, repeat as indicated
• Escalation triggers: RR >35, SpO2 <90% despite adequate O2 delivery, accessory muscle use, paradoxical breathing, altered mental status, hemodynamic instability, inability to clear secretions
• De-escalation criteria: stable gas exchange and hemodynamics for 24 hours off invasive support → step down monitoring intensity

16. ICU Bundle Checklist (Peri-Extubation)

17. Complications

Early:

• Reintubation-associated trauma (repeat laryngoscopy risk)
• Aspiration during the peri-extubation window
• Hemodynamic instability during reintubation (post-intubation hypotension, especially if fluid-restricted pre-extubation for cardiac reasons)
• Cardiac arrest during emergent reintubation (higher risk than the initial elective intubation)

Late:

• Prolonged mechanical ventilation from repeated failed attempts
• ICU-acquired weakness progression
• Post-extubation dysphagia (especially after prolonged intubation) → aspiration pneumonia
• Psychological sequelae of repeated failed extubation attempts (anxiety, PTSD)
• Need for tracheostomy after recurrent failure

Prevention: risk stratification before extubation, prophylactic NIV/HFNC in appropriate candidates, laryngeal edema prophylaxis, avoidance of premature extubation attempts

Rescue: early reintubation rather than prolonged rescue NIV trial once true failure is established

18. Escalation & De-escalation

Escalation triggers for reintubation (do not delay):

• Worsening gas exchange despite HFNC/NIV trial
• Hemodynamic instability
• Altered mental status / inability to protect airway
• Progressive stridor with distress
• Copious secretions the patient cannot clear

De-escalation:

• Wean HFNC/NIV support gradually once stable for 24 hours
• Transition to standard O2 delivery per usual weaning
• Discontinue continuous monitoring once stable respiratory and hemodynamic parameters sustained

Transfer/step-down criteria: stable gas exchange on minimal O2 support, no recurrent distress for 24–48 hours, secretions manageable, mental status at baseline

19. ICU Discharge Criteria (Post-Extubation Context)

• Stable spontaneous breathing without invasive or non-invasive support for ≥24–48 hours
• SpO2 maintained on ≤2–4 L nasal cannula or room air
• No stridor, no significant secretion burden
• Hemodynamically stable
• Mental status at or near baseline
• Swallow assessment cleared if prolonged intubation (>48–72 hours) or dysphagia risk factors present
• Adequate cough and airway protection reflexes

20. Documentation & Medicolegal Checklist

• Extubation readiness assessment documented, including SBT parameters and RSBI
• Cuff-leak test result (if performed) and rationale for steroid prophylaxis decision
• Explicit extubation checklist completion noted
• Post-extubation monitoring plan documented
• Any deterioration event: timeline, interventions, and decision-making rationale for reintubation vs. continued trial of non-invasive support
• Reintubation event: indication, difficulty encountered, complications
• Family communication regarding extubation plan and contingency for failure
• Multidisciplinary discussion documented for recurrent failures (≥2 attempts) prior to tracheostomy consideration

21. Key Guidelines

• ATS/ACCP 2017: Official executive summary on liberation from mechanical ventilation in critically ill adults (Schmidt, Girard, Kress et al.) — combined society guideline addressing SBT technique, RSBI use, cuff-leak testing, and extubation decision-making
• SCCM PADIS Guidelines 2018 (Devlin et al.): pain, agitation/sedation, delirium, immobility, and sleep disruption — directly relevant given the established link between sedation practice and weaning/extubation outcomes

22. Landmark Trials

23. Controversies

• RSBI cutoff value: originally proposed at 100, later studies and guidelines cite values up to 105; no universally agreed threshold, and RSBI alone has limited positive predictive value in modern ICU populations
• Cuff-leak test standardization: no consensus on technique (qualitative vs. quantitative, cutoff volume), producing inconsistent sensitivity/specificity across studies — some units have abandoned routine use in favor of direct/video laryngoscopy in high-risk patients
• Universal vs. selective prophylactic steroids: benefit is clearest in patients with a demonstrated absent/reduced cuff leak; routine use in all patients is not well supported and carries hyperglycemia/immunosuppression trade-offs
• HFNC vs. NIV as first-line prophylactic strategy: evidence supports both as reasonable in high-risk patients; institutional preference and patient tolerance often drive selection rather than a clear outcome-based hierarchy
• Optimal SBT duration and modality: PSV vs. T-piece, and 30 vs. 120 minutes, remain debated; current evidence favors shorter PSV trials but practice varies substantially between institutions
• Role of diaphragm ultrasound in routine practice: promising predictive data, but not yet incorporated into most formal weaning protocols or guideline-mandated decision-making

24. References

1. Schmidt GA, Girard TD, Kress JP, et al. Official executive summary of an American Thoracic Society/American College of Chest Physicians clinical practice guideline: liberation from mechanical ventilation in critically ill adults. Am J Respir Crit Care Med. 2017;195:115-119.
2. Yang KL, Tobin MJ. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med. 1991;324:1445-1450.
3. Esteban A, Frutos-Vivar F, Ferguson ND, et al. Non-invasive positive pressure ventilation for respiratory failure after extubation. N Engl J Med. 2004;350:2452-2460.
4. Ferrer M, Sellares J, Valencia M, et al. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet. 2009;374:1082-1088.
5. Hernandez G, Vaquero C, Colinas L, et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA. 2016;316(15):1565-1574.
6. Kuriyama A, Jackson JL, Kamei J. Performance of the cuff-leak test in adults in predicting post-extubation airway complications: a systematic review and meta-analysis. Crit Care. 2020;24(1):640.
7. Francois B, Bellissant E, Gissot V, et al. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet. 2007;369:1083-1089.
8. Fan T, Wang G, Mao B, et al. Prophylactic administration of parenteral steroids for preventing airway complications after extubation in adults: meta-analysis of randomised placebo controlled trials. BMJ. 2008;337:a1841.
9. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371:126-134.
10. Schweikert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373:1874-1882.
11. Devlin JW, Skrobik Y, Gelinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825-e873.
12. Llamas-Alvarez AM, Tenza-Lozano EM, Latour-Perez J. Diaphragm and lung ultrasound to predict weaning outcome: systematic review and meta-analysis. Chest. 2017;152:1140-1150.
13. The Washington Manual of Critical Care, 4th ed. 2025 — Chapter 18, Weaning from Mechanical Ventilation.
14. ICU Protocols: A Step-wise Approach, 2nd ed. — Chapter 33, Mechanical Ventilation.